Initial and Follow-up MR Imaging Findings in AIDS-Related Progressive Multifocal Leukoencephalopathy Treated with Highly Active Antiretroviral Therapy

References

1. ↵
   Berger JR, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. Neurovirol 1995;1:5-18
2. ↵
   Happe S, Besselmann M, Matheja P, et al. Therapy of progressive multifocal leukoencephalopathy (PML) in AIDS with cidofovir (Vistide): review of the literature and two case reports. Nervenarzt 1999;70:935-943

   CrossRefPubMedWeb of Science
3. ↵
   Portegies P, Algra PR, Hollak CEM, et al. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;337:680-681

   CrossRefPubMedWeb of Science
4. Nicoli F, Chave B, Peragut JC, Gastaut JL. Efficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991;339:306
5. De Luca A, Giancola ML, Cingolani A, et al. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 1999;28:624-628

   Abstract/FREE Full Text
6. ↵
   Miralles P, Berenguer J, Garcia de Viedma D, et al. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1998;12:2467-2472

   CrossRefPubMedWeb of Science
7. ↵
   Tassie JM, Gasnault J, Bentata M, et al. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. AIDS 1999;13:1881-1887

   CrossRefPubMedWeb of Science
8. ↵
   Giudici B, Vaz B, Bossolasco S, et al. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 2000;30:95-99

   Abstract/FREE Full Text
9. Baqi M, Kucharczyk W, Walmsley SL. Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1997;11:1526-1527

   PubMedWeb of Science
10. Teofilo E, Gouveia J, Brotas V, da Costa P. Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy. AIDS 1998;12:449

    PubMed
11. ↵
    Whiteman MLH, Post MJD, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993;187:233-240

    PubMedWeb of Science
12. ↵
    Post MJD, Yiannoutsos C, Simpson D, et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AJNR Am J Neuroradiol 1999;20:1896-1906

    Abstract/FREE Full Text
13. ↵
    Thurnher MM, Thurnher SA, Mühlbauer B, et al. Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI. Neuroradiology 1997;39:611-618

    CrossRefPubMedWeb of Science
14. ↵
    Kuchelmeister K, Gullotta F, Bergmann M, Angeli G, Masini T. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS): a neuropathological autopsy study of 21 cases. Pathol Res Pract 1993;189:163-173

    PubMed
15. ↵
    Dörries K. Virus-host interactions and diagnosis of human Polyomavirus-associated disease. Intervirology 1996;39:165-175

    PubMedWeb of Science
16. Wheeler AL, Truwit CL, Kleinschmidt-DeMasters BK, Byrne WR. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR imaging. AJR Am J Roentgenol 1993;161:1049-1051

    PubMedWeb of Science
17. Port JD, Miseljic S, Lee RR, et al. Progressive multifocal leukoencephalopathy demonstrating contrast enhancement on MRI and uptake of thallium-201: a case report. Neuroradiology 1999;41:895-898

    CrossRefPubMedWeb of Science
18. ↵
    Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome–associated progressive multifocal leukoencephalopathy. Ann Neurol 1998;44:341-349

    CrossRefPubMedWeb of Science
19. ↵
    Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS. Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status. Am J Med 1998;105:541-543

    CrossRefPubMedWeb of Science
20. Woo HH, Rezai AR, Knopp EA, et al. Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report. Neurosurgery 1996;39:1031-1035

    PubMedWeb of Science
21. ↵
    Collazos J, Mayo J, Martinez E, Blanco MS. Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 1999;13:1426-1428

    CrossRefPubMedWeb of Science
22. ↵
    Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K. Transactivation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci U S A 1990;87:3479-3483

    Abstract/FREE Full Text
23. ↵
    Entning RH, Hoetelmans MW, Lange JMA, Burger DM, Beijnen JH, Portehies P. Antiretroviral drugs and the central nervous system. AIDS 1998;12:1941-1955

    CrossRefPubMedWeb of Science
24. Flexner C. HIV-protease inhibitors. N Engl J Med 1998;338:1281-1292

    CrossRefPubMedWeb of Science
25. ↵
    Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ. Progressive multifocal leukoencephalopathy in AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 1999;28:1152-1154

    Abstract/FREE Full Text
26. ↵
    Mayo J, Collazos J, Martinez E. Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy. AIDS 1998;12:1720-1722

    PubMedWeb of Science